Literature DB >> 3132216

Oral iron chelating drugs: coming but not yet ready for clinical use.

C Hershko.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3132216      PMCID： PMC2545493          DOI： 10.1136/bmj.296.6629.1081

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  12 in total

1.  CARDIAC INVOLVEMENT IN COOLEY'S ANEMIA.

Authors:  M A ENGLE
Journal:  Ann N Y Acad Sci       Date:  1964-10-07       Impact factor: 5.691

Review 2.  Oxygen toxicity, oxygen radicals, transition metals and disease.

Authors:  B Halliwell; J M Gutteridge
Journal:  Biochem J       Date:  1984-04-01       Impact factor: 3.857

3.  Survival and desferrioxamine in thalassaemia major.

Authors:  B Modell; E A Letsky; D M Flynn; R Peto; D J Weatherall
Journal:  Br Med J (Clin Res Ed)       Date:  1982-04-10

4.  Mechanism of in vivo iron chelation by pyridoxal isonicotinoyl hydrazone and other imino derivatives of pyridoxal.

Authors:  C Hershko; S Avramovici-Grisaru; G Link; L Gelfand; S Sarel
Journal:  J Lab Clin Med       Date:  1981-07

5.  A study of intracellular iron metabolism using pyridoxal isonicotinoyl hydrazone and other synthetic chelating agents.

Authors:  P Ponka; J Borová; J Neuwirt; O Fuchs; E Necas
Journal:  Biochim Biophys Acta       Date:  1979-08-22

6.  Pyridoxal complexes as potential chelating agents for oral therapy in transfusional iron overload.

Authors:  A Williams; T Hoy; A Pugh; A Jacobs
Journal:  J Pharm Pharmacol       Date:  1982-11       Impact factor: 3.765

7.  Long-term chelation therapy in thalassaemia major: effect on liver iron concentration, liver histology, and clinical progress.

Authors:  M Barry; D M Flynn; E A Letsky; R A Risdon
Journal:  Br Med J       Date:  1974-04-06

8.  Phenolic ethylenediamine derivatives: a study of orally effective iron chelators.

Authors:  C Hershko; R W Grady; G Link
Journal:  J Lab Clin Med       Date:  1984-03

9.  Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major.

Authors:  L Wolfe; N Olivieri; D Sallan; S Colan; V Rose; R Propper; M H Freedman; D G Nathan
Journal:  N Engl J Med       Date:  1985-06-20       Impact factor: 91.245

10.  Orally active alpha-ketohydroxy pyridine iron chelators intended for clinical use: in vivo studies in rabbits.

Authors:  G J Kontoghiorghes; A V Hoffbrand
Journal:  Br J Haematol       Date:  1986-04       Impact factor: 6.998
View more
  4 in total

1.  Dietary and prophylactic iron supplements : Helpful or harmful?

Authors:  S Kent; E D Weinberg; P Stuart-Macadam
Journal:  Hum Nat       Date:  1990-03

2.  Transferrin iron starvation therapy for lethal bacterial and fungal infections.

Authors:  Lin Lin; Paul Pantapalangkoor; Brandon Tan; Kevin W Bruhn; Tiffany Ho; Travis Nielsen; Eric P Skaar; Yaofang Zhang; Ruipeng Bai; Amy Wang; Terence M Doherty; Brad Spellberg
Journal:  J Infect Dis       Date:  2014-01-19       Impact factor: 5.226

Review 3.  Anaemia in rheumatoid arthritis: pathogenesis, diagnosis and treatment.

Authors:  G Vreugdenhil; A J Swaak
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

Review 4.  Drug antioxidant effects. A basis for drug selection?

Authors:  B Halliwell
Journal:  Drugs       Date:  1991-10       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.